In pancreatic cancer patients, IGF2BP2 is associated with poorer prognosis, and mechanistically, IGF2BP2 plays as m6A reader for modification of lncRNA DANCR and stabilizes its mRNA 155. This evidence concerns the gene IGF2BP2 and familial pancreatic carcinoma.